NurExone Biologic Inc. Announces Second Quarter 2026 Financial Results

TORONTO and HAIFA, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) ("NurExone " or the "Company "), a biotechnology company developing exosome-based regenerative therapies,...